Co-Authors
This is a "connection" page, showing publications co-authored by Yazdan Yazdanpanah and François-Xavier Lescure.
Connection Strength
2.964
-
Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
Score: 0.874
-
Case report study of the first five COVID-19 patients treated with remdesivir in France. Int J Infect Dis. 2020 Sep; 98:290-293.
Score: 0.222
-
Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre. Clin Microbiol Infect. 2020 Jun; 26(6):669-672.
Score: 0.219
-
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review. Clin Microbiol Infect. 2018 Feb; 24(2):125-132.
Score: 0.181
-
Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France. Clin Microbiol Infect. 2017 Jun; 23(6):416-417.
Score: 0.174
-
Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France. BMC Infect Dis. 2021 Aug 13; 21(1):812.
Score: 0.060
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection. J Infect Dis. 2021 05 20; 223(9):1522-1527.
Score: 0.059
-
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc Natl Acad Sci U S A. 2021 02 23; 118(8).
Score: 0.058
-
Corrigendum to "Review of trials currently testing treatment and prevention of COVID-19" [Clin Microbiol Infect 26.8 (2020) 988-998]. Clin Microbiol Infect. 2021 Mar; 27(3):499.
Score: 0.058
-
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity. Nat Immunol. 2021 03; 22(3):322-335.
Score: 0.058
-
Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment. J Hypertens. 2021 02 01; 39(2):367-375.
Score: 0.058
-
Arterial Thrombotic Events in Adult Inpatients With COVID-19. Mayo Clin Proc. 2021 02; 96(2):295-303.
Score: 0.057
-
Clinical trial protocols of repurposed prophylaxis for COVID-19: A review. Infect Dis Now. 2021 02; 51(1):7-13.
Score: 0.057
-
Jaundice in a patient treated with Anakinra in a context of Covid-19. Infect Dis Now. 2021 Mar; 51(2):217-218.
Score: 0.057
-
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital. Int J Infect Dis. 2020 Dec; 101:49-51.
Score: 0.057
-
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection. J Clin Microbiol. 2020 Jul 23; 58(8).
Score: 0.056
-
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia. Cell Rep Med. 2020 07 21; 1(4):100059.
Score: 0.056
-
Review of trials currently testing treatment and prevention of COVID-19. Clin Microbiol Infect. 2020 Aug; 26(8):988-998.
Score: 0.055
-
Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020 06; 178:104791.
Score: 0.055
-
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. 2020 04; 46(4):579-582.
Score: 0.054
-
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):547-551.
Score: 0.052
-
Prescribers' experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey. J Antimicrob Chemother. 2019 08 01; 74(8):2451-2458.
Score: 0.052
-
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals. Clin Infect Dis. 2018 05 17; 66(11):1762-1769.
Score: 0.048
-
Experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study. Int J Antimicrob Agents. 2018 Jun; 51(6):829-835.
Score: 0.047
-
Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission. Clin Infect Dis. 2017 10 01; 65(7):1120-1126.
Score: 0.046
-
Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016. PLoS One. 2017; 12(7):e0180888.
Score: 0.045
-
Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study. J Clin Virol. 2017 06; 91:52-57.
Score: 0.045
-
Left ventricular assist pump pocket infection: conservative treatment strategy for destination therapy candidates. Int J Artif Organs. 2017 Apr 20; 0.
Score: 0.045